These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 21576125)

  • 1. Long-term and age-dependent restoration of visual function in a mouse model of CNGB3-associated achromatopsia following gene therapy.
    Carvalho LS; Xu J; Pearson RA; Smith AJ; Bainbridge JW; Morris LM; Fliesler SJ; Ding XQ; Ali RR
    Hum Mol Genet; 2011 Aug; 20(16):3161-75. PubMed ID: 21576125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of AAV5 Vectors Expressing Human or Canine CNGB3 in CNGB3-Mutant Dogs.
    Ye GJ; Komáromy AM; Zeiss C; Calcedo R; Harman CD; Koehl KL; Stewart GA; Iwabe S; Chiodo VA; Hauswirth WW; Aguirre GD; Chulay JD
    Hum Gene Ther Clin Dev; 2017 Dec; 28(4):197-207. PubMed ID: 29020838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAV-mediated cone rescue in a naturally occurring mouse model of CNGA3-achromatopsia.
    Pang JJ; Deng WT; Dai X; Lei B; Everhart D; Umino Y; Li J; Zhang K; Mao S; Boye SL; Liu L; Chiodo VA; Liu X; Shi W; Tao Y; Chang B; Hauswirth WW
    PLoS One; 2012; 7(4):e35250. PubMed ID: 22509403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six Years and Counting: Restoration of Photopic Retinal Function and Visual Behavior Following Gene Augmentation Therapy in a Sheep Model of
    Ofri R; Averbukh E; Ezra-Elia R; Ross M; Honig H; Obolensky A; Rosov A; Hauswirth WW; Gootwine E; Banin E
    Hum Gene Ther; 2018 Dec; 29(12):1376-1386. PubMed ID: 29926749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia: A Nonrandomized Controlled Trial.
    Fischer MD; Michalakis S; Wilhelm B; Zobor D; Muehlfriedel R; Kohl S; Weisschuh N; Ochakovski GA; Klein R; Schoen C; Sothilingam V; Garcia-Garrido M; Kuehlewein L; Kahle N; Werner A; Dauletbekov D; Paquet-Durand F; Tsang S; Martus P; Peters T; Seeliger M; Bartz-Schmidt KU; Ueffing M; Zrenner E; Biel M; Wissinger B
    JAMA Ophthalmol; 2020 Jun; 138(6):643-651. PubMed ID: 32352493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term retinal cone rescue using a capsid mutant AAV8 vector in a mouse model of CNGA3-achromatopsia.
    Dai X; He Y; Zhang H; Zhang Y; Liu Y; Wang M; Chen H; Pang JJ
    PLoS One; 2017; 12(11):e0188032. PubMed ID: 29131863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Augmentation Therapy Restores Retinal Function and Visual Behavior in a Sheep Model of CNGA3 Achromatopsia.
    Banin E; Gootwine E; Obolensky A; Ezra-Elia R; Ejzenberg A; Zelinger L; Honig H; Rosov A; Yamin E; Sharon D; Averbukh E; Hauswirth WW; Ofri R
    Mol Ther; 2015 Sep; 23(9):1423-33. PubMed ID: 26087757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Native cone photoreceptor cyclic nucleotide-gated channel is a heterotetrameric complex comprising both CNGA3 and CNGB3: a study using the cone-dominant retina of Nrl-/- mice.
    Matveev AV; Quiambao AB; Browning Fitzgerald J; Ding XQ
    J Neurochem; 2008 Sep; 106(5):2042-55. PubMed ID: 18665891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of cone cyclic nucleotide-gated channel leads to alterations in light response modulating system and cellular stress response pathways: a gene expression profiling study.
    Ma H; Thapa A; Morris LM; Michalakis S; Biel M; Frank MB; Bebak M; Ding XQ
    Hum Mol Genet; 2013 Oct; 22(19):3906-19. PubMed ID: 23740940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitreal delivery of AAV vectored Cnga3 restores cone function in CNGA3-/-/Nrl-/- mice, an all-cone model of CNGA3 achromatopsia.
    Du W; Tao Y; Deng WT; Zhu P; Li J; Dai X; Zhang Y; Shi W; Liu X; Chiodo VA; Ding XQ; Zhao C; Michalakis S; Biel M; Zhang Z; Qu J; Hauswirth WW; Pang JJ
    Hum Mol Genet; 2015 Jul; 24(13):3699-707. PubMed ID: 25855802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The B3 Subunit of the Cone Cyclic Nucleotide-gated Channel Regulates the Light Responses of Cones and Contributes to the Channel Structural Flexibility.
    Ding XQ; Thapa A; Ma H; Xu J; Elliott MH; Rodgers KK; Smith ML; Wang JS; Pittler SJ; Kefalov VJ
    J Biol Chem; 2016 Apr; 291(16):8721-34. PubMed ID: 26893377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy rescues cone function in congenital achromatopsia.
    Komáromy AM; Alexander JJ; Rowlan JS; Garcia MM; Chiodo VA; Kaya A; Tanaka JC; Acland GM; Hauswirth WW; Aguirre GD
    Hum Mol Genet; 2010 Jul; 19(13):2581-93. PubMed ID: 20378608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achromatopsia as a potential candidate for gene therapy.
    Pang JJ; Alexander J; Lei B; Deng W; Zhang K; Li Q; Chang B; Hauswirth WW
    Adv Exp Med Biol; 2010; 664():639-46. PubMed ID: 20238068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia.
    Ye GJ; Budzynski E; Sonnentag P; Nork TM; Miller PE; McPherson L; Ver Hoeve JN; Smith LM; Arndt T; Mandapati S; Robinson PM; Calcedo R; Knop DR; Hauswirth WW; Chulay JD
    Hum Gene Ther Clin Dev; 2016 Mar; 27(1):27-36. PubMed ID: 27003752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CNGB3 achromatopsia with progressive loss of residual cone function and impaired rod-mediated function.
    Khan NW; Wissinger B; Kohl S; Sieving PA
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3864-71. PubMed ID: 17652762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical Visual Mapping following Ocular Gene Augmentation Therapy for Achromatopsia.
    McKyton A; Averbukh E; Marks Ohana D; Levin N; Banin E
    J Neurosci; 2021 Sep; 41(35):7363-7371. PubMed ID: 34349002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired cone function and cone degeneration resulting from CNGB3 deficiency: down-regulation of CNGA3 biosynthesis as a potential mechanism.
    Ding XQ; Harry CS; Umino Y; Matveev AV; Fliesler SJ; Barlow RB
    Hum Mol Genet; 2009 Dec; 18(24):4770-80. PubMed ID: 19767295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient photoreceptor deconstruction by CNTF enhances rAAV-mediated cone functional rescue in late stage CNGB3-achromatopsia.
    Komáromy AM; Rowlan JS; Corr AT; Reinstein SL; Boye SL; Cooper AE; Gonzalez A; Levy B; Wen R; Hauswirth WW; Beltran WA; Aguirre GD
    Mol Ther; 2013 Jun; 21(6):1131-41. PubMed ID: 23568263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Therapy for Color Blindness.
    Hassall MM; Barnard AR; MacLaren RE
    Yale J Biol Med; 2017 Dec; 90(4):543-551. PubMed ID: 29259520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of the achromatopsia genes CNGA3 and CNGB3 in progressive cone dystrophy.
    Thiadens AA; Roosing S; Collin RW; van Moll-Ramirez N; van Lith-Verhoeven JJ; van Schooneveld MJ; den Hollander AI; van den Born LI; Hoyng CB; Cremers FP; Klaver CC
    Ophthalmology; 2010 Apr; 117(4):825-30.e1. PubMed ID: 20079539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.